Medigene AG Secures European Patent for its iM-TCR Technology - Seite 3

This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.

Medigene AG

Pamela Keck
Phone: [phone]
Email: [e-mail]

In case you no longer wish to receive any information about Medigene, please inform us by e-mail ([e-mail]). We will then delete your address from our distribution list.